ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, today announced a partnership with Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity. This partnership opens a significant opportunity for Protaonic's customers, says Frank Pieper. The partnership is a groundbreaking ecosystem of cutting-edge technology partners dedicated to driving innovation in customer R&D programs.